| Financial Year |
March 31 2023 |
| Monetary Funds |
203,707,008.99 |
| Held-for-trading Financial Assets |
392,640,454.61 |
| Notes Receivable |
11,473,910.00 |
| Accounts Receivable |
216,004,910.11 |
| Advances to Suppliers |
86,375,229.86 |
| Other Receivables |
17,104,094.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
338,408,788.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
150,672,126.21 |
| Total Current Assets |
1,577,043,684.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
185,673,735.76 |
| Under-construction Projects |
13,796,846.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,577,338.29 |
| R&D expenses |
-- |
| Goodwill |
22,965,825.41 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
26,897,826.23 |
| Other Non-Current Assets |
18,605,705.02 |
| Sub-Total of Non-Current Assets |
443,154,157.14 |
| Total Assets |
2,020,197,841.58 |
| Short-Term Loans |
527,513,062.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,937,376.89 |
| Accounts Payable |
327,566,830.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,439,041.90 |
| Taxes Payable |
3,718,140.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,007,636.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,744,181.62 |
| Other Current Liabilities |
27,380,465.67 |
| Sub-Total of Current Liabilities |
1,058,151,750.21 |
| Long-term Loans |
59,023,684.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
18,231,607.90 |
| Deferred Income Tax Liabilities |
3,967,755.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
150,527,146.56 |
| Total Liabilities |
1,208,678,896.77 |
| Paid-In Capital(Or Share Stock) |
80,173,000.00 |
| Capital Surplus |
362,314,236.25 |
| Surplus Reserve |
46,668,904.25 |
| LESS:Treasury Stock |
7,086,080.00 |
| Undistributed Profits |
323,284,292.89 |
| Minority Stockholder's Interest |
5,012,494.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
806,506,449.82 |
| Owner's Equity（Stockholder's Equity） |
811,518,944.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,020,197,841.58 |
